MiNK Therapeutics, Inc. (INKT) Net income 2020–2025
MiNK Therapeutics, Inc. (INKT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$12.5MFY2025 · since FY2020: -$16.2M → -$12.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.5M | -15.9% |
| FY2024 | -$10.8M | +52.0% |
| FY2023 | -$22.5M | +19.8% |
| FY2022 | -$28.0M | +7.4% |
| FY2021 | -$30.2M | -86.1% |
| FY2020 | -$16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INKT financial trends
INKT RevenueINKT Net marginINKT Gross profitINKT Gross marginINKT Operating incomeINKT Operating marginINKT Operating cash flowINKT Free cash flowINKT Capital expendituresINKT Return on equityINKT Stock buybacksINKT Dividends paidINKT Total assetsINKT Total liabilitiesINKT Shareholders’ equityINKT overview →